未登录

Y

Yang Liu

southern medical university - china

H指数:10

被引数:290

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer. (vol 12, 1861, 2023)

JOURNAL OF CLINICAL MEDICINE

IF2.9

2024-07-050

OAAI

Erectile function, urinary continence and oncologic outcomes of neurovascular bundle sparing robot-assisted radical prostatectomy for high-risk prostate cancer: A systematic review and meta-analysis

保留神经血管束的机器人辅助前列腺癌根治术治疗高危前列腺癌的勃起功能、控尿功能和肿瘤学结局的系统评价和meta分析

FRONTIERS IN ONCOLOGY

IF3.3

2023-04-055

OAAI

Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-02-273

OAAI

Plasma cell subtypes analyzed using artificial intelligence algorithm for predicting biochemical recurrence, immune escape potential, and immunotherapy response of prostate cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-12-086

OAAI

Rice supply flows and their determinants in China

RESOURCES CONSERVATION AND RECYCLING

IF10.9

2021-11-0112

PRE

A novel robust nomogram based on peripheral monocyte counts for predicting lymph node metastasis of prostate cancer

ASIAN JOURNAL OF ANDROLOGY

IF2.7

2021-07-011

OAAI

Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients

白人，黑人和亚洲前列腺癌患者药物代谢差异的综合特征分析

IF3.9

2021-06-1810

OAAI

M2 subtype tumor associated macrophages (M2-TAMs) infiltration predicts poor response rate of immune checkpoint inhibitors treatment for prostate cancer

ANNALS OF MEDICINE

IF4.3

2021-05-2516

OAAI

Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy

JOURNAL OF UROLOGY

IF6.8

2021-05-017

OA